Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A terminal disease intercepted by modern medicine

Gene Uzawa Dorio, MD
Conditions
October 29, 2024
Share
Tweet
Share

I have been a physician for over forty years, with an office practice and providing geriatric house calls in our community. Now, I am also a caregiver.

My partner, Robin, was diagnosed with a rare malignancy in November 2022, known as anaplastic thyroid cancer. She was given six months to live.

Surgery to remove what they could took 9 1/2 hours, and seven weeks of subsequent radiation and chemotherapy helped slow it down. Traditional medicine using surgery, radiation, and chemotherapy is at an inflection point and has been augmented by techniques that unravel DNA.

Biomarker analysis of her tumor revealed a mutation in the cancer and suggested certain new drugs within the realm of immunology and targeted medication might be used to interfere with the progression.

Immunotherapy using Keytruda was started by intravenous infusion every three weeks to enhance the body’s white blood cells’ ability to attack the cancer.

Once the cancer was found to have spread to her thigh and lungs at the end of December 2023, it was decided to add a targeted medication. This oral drug was Retevmo.

After four weeks, Retevmo had to be stopped because of abnormal elevation in liver tests, but on the same day it was halted, a PET/CT scan had been scheduled.

Mind you, after only four weeks of Retevmo treatment, the previously positive PET/CT scan revealed no evidence of disease (NED). A clinical trial using a blood test known as ctDNA, which measures specific cancer cells in her bloodstream that were positive in the past, was now negative. Four subsequent scans this year, as well as the blood tests, have shown NED, while Robin is now on a daily oral dose of a drug similar to Retevmo, Gavreto.

Oncology specialists will not use the word cured for this type of cancer, as time will better define this hopeful word as the unfolding of more data on her and other patients is collected.

Robin’s medical care was guided by a team of health care professionals coordinated by oncologists at Cedars-Sinai Medical Center in Los Angeles. The science behind their treatment plan was new, so they referred us to MD Anderson Cancer Center in Houston for collaborative care.

Our journey is still bumpy, and medical decision-making does not always have an unequivocal yes or no answer.

Stumbling blocks have arisen from more than medication side effects or travel expenses. Insurance companies initially played a role in the denial of testing even though it was ordered by the foremost doctors and experts in the world.

One example was when MD Anderson ordered a PET/CT scan, but when we came for the appointment in Houston and arrived in the waiting room, we were told the insurance company had denied the test. I was on the phone for 3 ½ hours with multiple insurance representatives, explaining the importance and need for the testing while other patients in the waiting room listened to my pleadings. Finally, they agreed, and the waiting room patients and staff erupted in applause and cheered the fought-over decision with us!

ADVERTISEMENT

The targeted medication cost was shocking: Retevmo was $30,000 per month. Fortunately, Cedars-Sinai helped us negotiate with the pharmaceutical company as we were considered a special need secondary to the terminal diagnosis.

Robin and I have attempted to inform the public of these new treatments against cancer and were featured in the Los Angeles Times by columnist Steve Lopez (April 13, 2024). Plus, we have enlightened many older adults in the Santa Clarita Valley through our senior center. A volunteer at the center told us her 31-year-old daughter had stage IV uterine cancer, and she was a veteran treated at a local VA hospital.

A biopsy report was provided to me by her family, and I noticed there was no biomarker analysis done on her cancer. From that, and through other research, we found less than 20% of VA patients have biomarker testing done on their pathology reports and, therefore, would not be able to benefit from the new tools using immunotherapy or targeted treatment. The cost of this test presently is under $300.

Also, during our ordeal, executive orders related to the COVID-19 pandemic ended, so having a telehealth Zoom visit crossing state lines with MD Anderson in Texas was illegal. This, of course, hampered communication with our experts in Houston, as their doctors were not licensed by the state of California. Our online national support group, which we joined through MD Anderson, had many participants facing the same problem.

Robin and I are assembly members of the California Senior Legislature, so we wrote two proposals to be presented in October to state and federal legislatures addressing these problems:

1. Request the VA to provide biomarker analysis on all veteran biopsies so they might be provided the opportunity to consider treatment with new immunotherapy and targeted medication.

2. Ask the California legislature to restore the ability for cancer patients to have telehealth Zoom visits from out-of-state oncology physicians.

Since our governor and president are “lame duck,” we have also asked them to consider executive order legislation to jumpstart these initiatives, as time is of the essence in fighting cancer.

Traditional cancer treatment using surgery, radiation, and chemotherapy might soon be supplanted by more effective immunotherapy and targeted medication, but we are still on a learning curve. Evidence-based data must continue to be collected, and participants must be mindful of all side effects of these new medicines.

Many doctors, even some oncologists, are unaware of these new treatments. Plus, if you live in rural areas, you may not have nearby specialists who know about advancing medical care, and many primary care doctors need to be made aware of this new science.

For the moment, it is best to seek care at prominent teaching institutes or centers of excellence, with patients encouraged to ask their local doctor for assistance in finding this care.

More importantly, should you be told you have a diagnosis of cancer, be sure to have a biomarker analysis done looking for DNA mutations, as it might expand your treatment plan and improve your survival chance.

Our goal is to continue to inform the public of advances in cancer treatment, and bring equity and better doctor-patient communication to all those, especially veterans, who might be diagnosed with this dreaded disease. Statistically, cancer is number two on the top ten list of leading causes of death in the United States. It is time we make every effort to get it off the top ten list forever.

Being a physician and providing house calls prepared me to be a better caregiver to Robin. However, it also gave me new skills, allowing me to continue fulfilling my duty as a doctor to the people I serve.

Gene Uzawa Dorio is an internal medicine physician who blogs at SCV Physician Report.

Prev

AI medical scribes: Boosting efficiency or risking over-reliance?

October 29, 2024 Kevin 1
…
Next

A surgeon's insight into the future of health care staffing [PODCAST]

October 29, 2024 Kevin 0
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
AI medical scribes: Boosting efficiency or risking over-reliance?
Next Post >
A surgeon's insight into the future of health care staffing [PODCAST]

ADVERTISEMENT

More by Gene Uzawa Dorio, MD

  • How doctors took back control from hospital executives

    Gene Uzawa Dorio, MD
  • Pope Francis dies at 88. What his care reveals about America’s failing hospitals.

    Gene Uzawa Dorio, MD
  • When saving lives leads to losing your own

    Gene Uzawa Dorio, MD

Related Posts

  • From penicillin to digital health: the impact of social media on medicine

    Homer Moutran, MD, MBA, Caline El-Khoury, PhD, and Danielle Wilson
  • Medicine won’t keep you warm at night

    Anonymous
  • Delivering unpalatable truths in medicine

    Samantha Cheng
  • How women in medicine are shaping the future of medicine [PODCAST]

    American College of Physicians & The Podcast by KevinMD
  • What medicine can learn from a poem

    Thomas L. Amburn
  • Medicine, fast and slow

    Claire Brown

More in Conditions

  • How President Biden’s cognitive health shapes political and legal trust

    Muhamad Aly Rifai, MD
  • The emotional first responders of aesthetic medicine

    Sarah White, APRN
  • Why testosterone matters more than you think in women’s health

    Andrea Caamano, MD
  • How veteran health care is being transformed by tech and teamwork

    Deborah Lafer Scher
  • What Elon Musk and Diddy reveal about the price of power

    Osmund Agbo, MD
  • Understanding depression beyond biology: the power of therapy and meaning

    Maire Daugharty, MD
  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

A terminal disease intercepted by modern medicine
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...